FTC sues significant pharmacy advantage managers over insulin prices The company brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist cost of life-preserving insulin medications. The offer have to be accomplished by Sept. 30 or prospective buyers can terminate https://daveshotchickennutrition63962.ziblogs.com/30740587/everything-about-healthcare-news